Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Richard V. Milani, MD, FACC*,*,
Carl J. Lavie, MD, FACC* and
Mandeep R. Mehra, MD, FACC*
* Cardiovascular Health Center, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
View larger version (17K):
[in a new window]
|
Figure 1 Median changes in high-sensitivity C-reactive protein (HSCRP) in cardiac rehabilitation and in control patients with coronary heart disease (CHD).
|
|
View larger version (13K):
[in a new window]
|
Figure 2 Distribution of high-sensitivity C-reactive protein (HSCRP) in patients with coronary artery disease (n = 235) before and after cardiac rehabilitation and exercise training.
|
|
View larger version (15K):
[in a new window]
|
Figure 3 Change in high-sensitivity C-reactive protein (HSCRP) following cardiac rehabilitation and exercise training in patients taking statins (n = 143) and in patients not taking statins (n = 82).
|
|
View larger version (14K):
[in a new window]
|
Figure 4 Changes in high-sensitivity C-reactive protein (HSCRP) following cardiac rehabilitation and exercise training in patients who achieved weight loss (n = 121) versus patients who gained weight (n = 106).
|
|
|
